Literature DB >> 20086092

Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans.

Kristy L B Mount1, Carisa A Townsend, Sherri D Rinker, Xiaoping Gu, Kate R Fortney, Beth W Zwickl, Diane M Janowicz, Stanley M Spinola, Barry P Katz, Margaret E Bauer.   

Abstract

Haemophilus ducreyi is an extracellular pathogen of human epithelial surfaces that resists human antimicrobial peptides (APs). The organism's genome contains homologs of genes sensitive to antimicrobial peptides (sap operon) in nontypeable Haemophilus influenzae. In this study, we characterized the sap-containing loci of H. ducreyi 35000HP and demonstrated that sapA is expressed in broth cultures and H. ducreyi-infected tissue; sapA is also conserved among both class I and class II H. ducreyi strains. We constructed a nonpolar sapA mutant of H. ducreyi 35000HP, designated 35000HPsapA, and compared the percent survival of wild-type 35000HP and 35000HPsapA exposed to several human APs, including alpha-defensins, beta-defensins, and the cathelicidin LL-37. Unlike an H. influenzae sapA mutant, strain 35000HPsapA was not more susceptible to defensins than strain 35000HP was. However, we observed a significant decrease in the survival of strain 35000HPsapA after exposure to LL-37, which was complemented by introducing sapA in trans. Thus, the Sap transporter plays a role in resistance of H. ducreyi to LL-37. We next compared mutant strain 35000HPsapA with strain 35000HP for their ability to cause disease in human volunteers. Although both strains caused papules to form at similar rates, the pustule formation rate at sites inoculated with 35000HPsapA was significantly lower than that of sites inoculated with 35000HP (33.3% versus 66.7%; P = 0.007). Together, these data establish that SapA acts as a virulence factor and as one mechanism for H. ducreyi to resist killing by antimicrobial peptides. To our knowledge, this is the first demonstration that an antimicrobial peptide resistance mechanism contributes to bacterial virulence in humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20086092      PMCID: PMC2825904          DOI: 10.1128/IAI.01014-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  The TyrR regulon.

Authors:  James Pittard; Helen Camakaris; Ji Yang
Journal:  Mol Microbiol       Date:  2005-01       Impact factor: 3.501

2.  A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media.

Authors:  Kevin M Mason; Robert S Munson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.

Authors:  L Liu; L Wang; H P Jia; C Zhao; H H Heng; B C Schutte; P B McCray; T Ganz
Journal:  Gene       Date:  1998-11-19       Impact factor: 3.688

4.  Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS).

Authors:  J E Graham; J E Clark-Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Haemophilus ducreyi Outer membrane determinants, including DsrA, define two clonal populations.

Authors:  Catherine Dinitra White; Isabelle Leduc; Bonnie Olsen; Chrystina Jeter; Chavala Harris; Christopher Elkins
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

7.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

8.  Target cell range of Haemophilus ducreyi hemolysin and its involvement in invasion of human epithelial cells.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 9.  Treatment of chancroid in resource-poor countries.

Authors:  Naa Torshie Annan; David A Lewis
Journal:  Expert Rev Anti Infect Ther       Date:  2005-04       Impact factor: 5.091

10.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more
  19 in total

1.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Rapid divergence of two classes of Haemophilus ducreyi.

Authors:  Emily E Ricotta; Nan Wang; Robin Cutler; Jeffrey G Lawrence; Tricia L Humphreys
Journal:  J Bacteriol       Date:  2011-04-22       Impact factor: 3.490

3.  Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.

Authors:  Sherri D Rinker; Michael P Trombley; Xiaoping Gu; Kate R Fortney; Margaret E Bauer
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

4.  Carbon storage regulator A contributes to the virulence of Haemophilus ducreyi in humans by multiple mechanisms.

Authors:  Dharanesh Gangaiah; Wei Li; Kate R Fortney; Diane M Janowicz; Sheila Ellinger; Beth Zwickl; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

5.  Permeases of the sap transporter are required for cathelicidin resistance and virulence of Haemophilus ducreyi in humans.

Authors:  Sherri D Rinker; Xiaoping Gu; Kate R Fortney; Beth W Zwickl; Barry P Katz; Diane M Janowicz; Stanley M Spinola; Margaret E Bauer
Journal:  J Infect Dis       Date:  2012-08-28       Impact factor: 5.226

Review 6.  On the in vivo significance of bacterial resistance to antimicrobial peptides.

Authors:  Margaret E Bauer; William M Shafer
Journal:  Biochim Biophys Acta       Date:  2015-02-18

Review 7.  Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Authors:  Jason N Cole; Victor Nizet
Journal:  Microbiol Spectr       Date:  2016-02

8.  Activation of CpxRA in Haemophilus ducreyi primarily inhibits the expression of its targets, including major virulence determinants.

Authors:  Dharanesh Gangaiah; Xinjun Zhang; Kate R Fortney; Beth Baker; Yunlong Liu; Robert S Munson; Stanley M Spinola
Journal:  J Bacteriol       Date:  2013-05-31       Impact factor: 3.490

Review 9.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29

10.  SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus.

Authors:  Andrew R Vogel; Blake R Szelestey; Forrest K Raffel; Samantha W Sharpe; Rachel L Gearinger; Sheryl S Justice; Kevin M Mason
Journal:  Front Cell Infect Microbiol       Date:  2012-04-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.